申请人:Novartis AG
公开号:US08143278B2
公开(公告)日:2012-03-27
The present invention provides a compound of formula I:
said compound is inhibitor of aldosterone synthase, and/or 11beta-hydroxylase (CYP11B1), and thus can be employed for the treatment of a disorder or disease mediated by aldosterone synthase and/or CYP11B1. Finally, the present invention also provides a pharmaceutical composition.
本发明提供了一种I式化合物,该化合物是醛固酮合成酶和/或11beta-羟化酶(CYP11B1)的抑制剂,因此可用于治疗由醛固酮合成酶和/或CYP11B1介导的疾病或疾病。最后,本发明还提供了一种制药组合物。